One in five relatives of ECG-positive phenotype-negative adolescents received a cardiomyopathy diagnosis or had early cardiomyopathy traits, and a joint clinical-genetic approach may aid early detection in selected families, though findings remain exploratory and require validation in larger cohorts.
Key Findings
Results
Only a small proportion of adolescents screened nationally met criteria as ECG-positive phenotype-negative, and a minority of these carried a pathogenic cardiomyopathy variant.
Sixteen adolescents (0.6%) met inclusion criteria.
Three of 16 (18.8%) were genotype-positive (G+).
The variants were in MYBPC3, MYH7 and ACTC1.
Adolescents were identified through a nationwide screening program and underwent comprehensive clinical/genetic evaluation in a prospective cohort design.
Results
About one in five relatives of these adolescents were referred after clinical screening, mostly because of an abnormal ECG.
13 of 71 relatives (18.3%; 95% CI 11.0-28.9%) were referred.
An abnormal ECG was the most common reason for referral (12.7%).
Results
Early cardiomyopathy traits were present at baseline in a sizeable proportion of relatives.
Nine relatives (12.7%; 95% CI 4.9-20.4%) exhibited early cardiomyopathy traits at baseline.
The abstract's 'what is new' summary reports early traits in 11.3% of relatives.
Results
Cardiomyopathy was newly diagnosed in a few relatives at baseline.
Three relatives (4.2%, 95% CI 0.9-11.8%) were diagnosed at baseline.
The diagnoses were 2 hypertrophic cardiomyopathy (HCM) and 1 dilated cardiomyopathy (DCM).
Results
Cascade genetic testing identified one gene-positive/phenotype-negative relative.
One relative (1.4%) was G+/P-.
Cascade genetic testing was offered when probands carried a likely/definite pathogenic cardiomyopathy variant.
Results
One relative with early traits phenoconverted during follow-up, bringing the overall diagnostic rate to 5.6%.
The phenoconversion was to non-dilated left ventricular cardiomyopathy (NDLVC) at 77 months.
The overall diagnostic rate was 5.6% (95% CI 2.0-13.8%).
Diagnoses were spread across 4 unrelated families.
Results
A joint clinical-genetic approach enabled personalized surveillance for some relatives and identified diagnoses that conventional clinical screening alone would have missed.
Personalized surveillance was enabled in 6 relatives (8.5%).
Two diagnoses (2.8%) would otherwise have been missed with conventional clinical screening.
Conclusions
The authors conclude that extending family screening to relatives of ECG-positive phenotype-negative adolescents is justified, while noting findings are exploratory.
One in five relatives received a cardiomyopathy diagnosis or had early cardiomyopathy traits.
The authors note that cardiomyopathy penetrance is age dependent, which may explain abnormal ECG patterns in adolescents without a diagnosis.
Validation in larger cohorts is required.
What This Means
Some teenagers have an abnormal heart tracing (ECG) on screening even though detailed tests show no heart muscle disease. This study asked whether it is worthwhile to test their family members, and whether adding genetic testing to the usual heart checks helps. Out of a nationwide screening program, only 16 adolescents (0.6%) fit this description, and 3 of them carried a disease-causing gene variant linked to heart muscle disease.
Among 71 relatives, about 1 in 5 had either a new heart muscle disease diagnosis or early signs of one. Three relatives (4.2%) were diagnosed at the start, and one more developed a condition years later (at 77 months), for an overall diagnosis rate of 5.6%. Combining genetic and clinical evaluation allowed tailored follow-up for 6 relatives and uncovered 2 diagnoses that standard clinical screening alone would likely have missed.
This research suggests that checking relatives of such adolescents may help find heart muscle disease early in some families. However, the study was small, involving few families, so the authors describe the results as exploratory and say larger studies are needed to confirm them.
Abela M, Debattista J, Scerri J, Felice T, Grech V, Scerri C. (2026). Family screening for genetic cardiomyopathies in ECG-positive phenotype-negative adolescents: a joint clinical and genetic approach.. European journal of pediatrics. https://doi.org/10.1007/s00431-026-07524-y